Lenire, a trusted shape on the undynamic tinnitus landscape - VIDEO INTERVIEW

The global medical technology company, Neuromod Devices, has been around since 2010, developing among its protected patents a bimodal neuromodulation device for tinnitus treatment: Lenire. Awarded in 2014 the CE Mark in Europe in, in 2023 Lenire became the first tinnitus treatment device of its kind to be awarded FDA approval.

Peter WIX, Published on 03 November 2025

Lenire, a trusted shape on the undynamic tinnitus landscape – VIDEO INTERVIEW
The landscape for a challenging condition such as tinnitus is not known for its fast evolution. So, when a promising change comes along in the shape of good results for a tinnitus treatment, eyes and ears open to learn what's new. Lenire, a treatment option backed by institutional endorsement and intriguing study results, is one of those attention-grabbing developments. Tinnitus is "not easy - there's no cure for it", underlines our guest interviewee in the latest Audiology Worldnews video, Andrew Coulter, VP - Europe for Neuromod Devices. A respected figure in the UK audiology scene, and former President of the British Society of Hearing Aid Audiologists, Coulter is now known globally for his different roles in hearing health. Responding to visitors over three days at the Neuromod stand during the recent EUHA Congress in Nuremberg, he represented his company's flagship tinnitus treatment system, Lenire. Watch both...

This content is only accessible to registered users of the website audiology worldnews

Register for free to read more
In the same section
  • Awareness
  • Events
  • Events
  • Market
  • Market
  • Profession
  • Profession
  • Research
  • Research
  • Training and Education
  • Awareness
  • Awareness
  • Events
  • Events
  • Market
  • Opinion
  • Profession
  • Research
  • Training and Education
  • WORLD NEWS